Clindamycin phosphate and Bipolar disorder - a phase IV clinical study of FDA data

Summary:

Bipolar disorder is reported as a side effect among people who take Clindamycin phosphate (clindamycin phosphate), especially for people who are male, 10-19 old, also take Xyrem, and have Cataplexy.

The phase IV clinical study analyzes which people have Bipolar disorder when taking Clindamycin phosphate. It is created by eHealthMe based on reports of 3,863 people who have side effects when taking Clindamycin phosphate from the FDA, and is updated regularly.

What is Clindamycin phosphate?

Clindamycin phosphate has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 4,216 Clindamycin phosphate users. Check the latest studies of Clindamycin phosphate.

What is Bipolar disorder?

Bipolar disorder (mood disorder) is found to be associated with 907 drugs and 1,231 conditions by eHealthMe. Check the latest studies of Bipolar disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

3,863 people reported to have side effects when taking Clindamycin phosphate.
Among them, 13 people (0.34%) have Bipolar disorder.

Could Clindamycin phosphate cause Bipolar disorder?

Among these 13 people:

What is the gender of people who have Bipolar disorder when taking Clindamycin phosphate? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Bipolar disorder when taking Clindamycin phosphate? *

What are other drugs people take besides Clindamycin phosphate? *

What are other side effects people have besides Bipolar disorder? *

Suicidal Ideation: 11 people, 84.62%
Headache (pain in head): 11 people, 84.62%
Depression: 8 people, 61.54%
Stress And Anxiety: 8 people, 61.54%
Weight Decreased: 6 people, 46.15%
Nasopharyngitis (inflammation of the nasopharynx): 6 people, 46.15%
Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 6 people, 46.15%
Catatonia (unresponsive to external stimuli): 6 people, 46.15%
Drug Dependence: 6 people, 46.15%
Dyspnea (difficult or laboured breathing): 6 people, 46.15%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 100.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 100.00%
Drowsiness: 6 people, 46.15%

* Approximation only. Some reports may have incomplete information.

Do you take Clindamycin phosphate and have Bipolar disorder?

- Check whether Bipolar disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clindamycin phosphate:

Clindamycin phosphate (4,216 reports)

Bipolar disorder treatments and more:

Bipolar disorder (109,431 reports)

Browse all side effects of Clindamycin phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bipolar disorder:

Bipolar disorder (907 drugs)

Browse all the conditions that are associated with Bipolar disorder:

Bipolar disorder (1,231 conditions)

Related publications that referenced our studies

Ayano G, "Bipolar Disorders and Valproate: Pharmacokinetics, Pharmacodynamics and Therapeutic Effects and Indications of Valproate: Review of Articles", Bipolar Disord, 2017 Jan .
Ayano G, "Bipolar Disorders and Valproate: Pharmacokinetics, Pharmacodynamics and Therapeutic Effects and Indications of Valproate: Review of Articles", Bipolar Disord, 2017 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on clindamycin phosphate (the active ingredients of Clindamycin phosphate) and Clindamycin phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.